[Combined treatment of esophageal small cell carcinoma with radiation and chemotherapy]. 1990

H Kobayashi, and S Koyama, and Y Chuganji, and N Kawanishi, and S Hotta, and H Fukutomi, and T Osuga, and K Nakamura
Dept. of Int. Med. Institute of Clinical Medicine, University of Tsukuba.

A 61-year-old male complaining of dysphagia and precordial chest pain was admitted to hospital. A series of upper G.I. examinations revealed an ulcerative tumor, approximately 8 cm in diameter, in the esophagus. A biopsy of a specimen led to the histological diagnosis of a small cell carcinoma (oat cell type). The cells were uniformly argentaffin-negative (Masson-Fontna) and many contained numerous tiny argyrophylic granules (Grimelius). Therefore, a combined therapy of radiation (70 Gy) and CDDP (total dose: 210 mg) was used to treat the lesion, and the disappearance of the mass shadow, as well as no narrowing of the esophagus, was noted without residual ulceration, indicating a complete response. Four months after the therapy, however, an extensive multiple liver metastasis occurred, and the patient died of hepatic and renal failure. His overall survival time was 7 months from start of the combined therapy. It thus is felt that a multi-drug regimen and systemic chemotherapy are important in treating small cell carcinomas of the esophagus.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D012074 Remission Induction Therapeutic act or process that initiates a response to a complete or partial remission level. Induction of Remission,Induction, Remission,Inductions, Remission,Remission Inductions
D002945 Cisplatin An inorganic and water-soluble platinum complex. After undergoing hydrolysis, it reacts with DNA to produce both intra and interstrand crosslinks. These crosslinks appear to impair replication and transcription of DNA. The cytotoxicity of cisplatin correlates with cellular arrest in the G2 phase of the cell cycle. Platinum Diamminodichloride,cis-Diamminedichloroplatinum(II),cis-Dichlorodiammineplatinum(II),Biocisplatinum,Dichlorodiammineplatinum,NSC-119875,Platidiam,Platino,Platinol,cis-Diamminedichloroplatinum,cis-Platinum,Diamminodichloride, Platinum,cis Diamminedichloroplatinum,cis Platinum
D003131 Combined Modality Therapy The treatment of a disease or condition by several different means simultaneously or sequentially. Chemoimmunotherapy, RADIOIMMUNOTHERAPY, chemoradiotherapy, cryochemotherapy, and SALVAGE THERAPY are seen most frequently, but their combinations with each other and surgery are also used. Multimodal Treatment,Therapy, Combined Modality,Combined Modality Therapies,Modality Therapies, Combined,Modality Therapy, Combined,Multimodal Treatments,Therapies, Combined Modality,Treatment, Multimodal,Treatments, Multimodal
D004938 Esophageal Neoplasms Tumors or cancer of the ESOPHAGUS. Cancer of Esophagus,Esophageal Cancer,Cancer of the Esophagus,Esophagus Cancer,Esophagus Neoplasm,Neoplasms, Esophageal,Cancer, Esophageal,Cancer, Esophagus,Cancers, Esophageal,Cancers, Esophagus,Esophageal Cancers,Esophageal Neoplasm,Esophagus Cancers,Esophagus Neoplasms,Neoplasm, Esophageal,Neoplasm, Esophagus,Neoplasms, Esophagus
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D018288 Carcinoma, Small Cell An anaplastic, highly malignant, and usually bronchogenic carcinoma composed of small ovoid cells with scanty neoplasm. It is characterized by a dominant, deeply basophilic nucleus, and absent or indistinct nucleoli. (From Stedman, 25th ed; Holland et al., Cancer Medicine, 3d ed, p1286-7) Carcinoma, Oat Cell,Oat Cell Carcinoma,Small Cell Carcinoma,Carcinomas, Oat Cell,Carcinomas, Small Cell,Oat Cell Carcinomas,Small Cell Carcinomas

Related Publications

H Kobayashi, and S Koyama, and Y Chuganji, and N Kawanishi, and S Hotta, and H Fukutomi, and T Osuga, and K Nakamura
March 1994, Lung cancer (Amsterdam, Netherlands),
H Kobayashi, and S Koyama, and Y Chuganji, and N Kawanishi, and S Hotta, and H Fukutomi, and T Osuga, and K Nakamura
August 2007, Pathology international,
H Kobayashi, and S Koyama, and Y Chuganji, and N Kawanishi, and S Hotta, and H Fukutomi, and T Osuga, and K Nakamura
November 1982, The Annals of thoracic surgery,
H Kobayashi, and S Koyama, and Y Chuganji, and N Kawanishi, and S Hotta, and H Fukutomi, and T Osuga, and K Nakamura
January 1995, The Journal of infusional chemotherapy,
H Kobayashi, and S Koyama, and Y Chuganji, and N Kawanishi, and S Hotta, and H Fukutomi, and T Osuga, and K Nakamura
April 1977, Radiology,
H Kobayashi, and S Koyama, and Y Chuganji, and N Kawanishi, and S Hotta, and H Fukutomi, and T Osuga, and K Nakamura
February 1983, European journal of respiratory diseases,
H Kobayashi, and S Koyama, and Y Chuganji, and N Kawanishi, and S Hotta, and H Fukutomi, and T Osuga, and K Nakamura
April 1985, Cancer,
H Kobayashi, and S Koyama, and Y Chuganji, and N Kawanishi, and S Hotta, and H Fukutomi, and T Osuga, and K Nakamura
January 1993, Rays,
H Kobayashi, and S Koyama, and Y Chuganji, and N Kawanishi, and S Hotta, and H Fukutomi, and T Osuga, and K Nakamura
December 2001, Lung cancer (Amsterdam, Netherlands),
H Kobayashi, and S Koyama, and Y Chuganji, and N Kawanishi, and S Hotta, and H Fukutomi, and T Osuga, and K Nakamura
June 1988, Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al],
Copied contents to your clipboard!